Contraline

United States · Biotech · Healthtech · Enterprise software

Develops hormonal and non-hormonal male contraceptives for men and couples globally

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series B$92.5MBVF Partners L.P. — Role not disclosedGV (Google Ventures) — Role not disclosedInvus — Role not disclosedLumira Ventures — Role not disclosedRA Capital Management — Role not disclosed
Sourcescontraline.com ↗